All awarded grants

University of Melbourne – Kanta Subbarao

The Novo Nordisk Foundation has awarded a grant of DKK 13,834,409 to Melbourne researchers to support the late pre-clinical development of a novel long-acting pan-influenza antiviral drug that will be accessible for people in low- and middle-income countries.

Read more

Stanford University – Karla Kirkegaard

Bill & Melinda Gates Foundation has awarded a grant of USD 2,178,521 to support identification of conformational modulators of influenza virus M1 protein as antivirals with a high barrier to resistance for pandemic preparedness.

Read more

Exscientia – Ian Goodfellow

Open Philanthropy has awarded a grant of USD 2.3 million to support research into the host interferon response as a pathway to treating and preventing pandemic influenza.

Read more